OncoMyx Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- OncoMyx Therapeutics's estimated annual revenue is currently $1.2M per year.
- OncoMyx Therapeutics's estimated revenue per employee is $201,000
Employee Data
- OncoMyx Therapeutics has 6 Employees.
- OncoMyx Therapeutics grew their employee count by -50% last year.
OncoMyx Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Operations | Reveal Email/Phone |
2 | VP People | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Scientist, Oncolytic Virotherapy | Reveal Email/Phone |
6 | CMC Advisor | Reveal Email/Phone |
7 | Finance Advisor | Reveal Email/Phone |
OncoMyx Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $22.3M | 111 | 8% | N/A | N/A |
#2 | $17.7M | 88 | -19% | N/A | N/A |
#3 | $6.6M | 33 | -8% | N/A | N/A |
#4 | $29.1M | 145 | 48% | N/A | N/A |
#5 | $1.2M | 6 | -50% | N/A | N/A |
#6 | $2.2M | 11 | 10% | N/A | N/A |
#7 | $4.8M | 24 | -17% | N/A | N/A |
#8 | $34.8M | 173 | 5% | N/A | N/A |
#9 | $46.2M | 230 | 5% | N/A | N/A |
#10 | $3.2M | 16 | -11% | N/A | N/A |
What Is OncoMyx Therapeutics?
OncoMyx Therapeutics targets hematologic and solid tumors with unique oncolytic virus called myxoma (MYXV) and a novel patented systemic delivery approach. The myxoma program is the result of two decades of oncolytic virus research in the laboratory of Professor Grant McFadden. Myxoma is a pox virus that is highly immunostimulatory, and is non-pathogenic in any organism outside of rabbits. The virus has a unique ability to be carried systemically by human leukocytes where it can then infect tumor cells. Programs are in development for both hematology (myeloma and AML) as well as solid tumors. Professor McFadden sequenced the myxoma virus genome in 1999, and since then has produced dozens of genetically engineered constructs, demonstrating its ability as an oncolytic agent across many tumors in preclinical cell and animal models.
keywords:N/A
N/A
Total Funding
6
Number of Employees
$1.2M
Revenue (est)
-50%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OncoMyx Therapeutics News
"Companies like OncoMyx Therapeutics are developing innovative treatments, and our health-care leaders are working to address current needs...
OncoMyx Therapeutics is advancing multi-armed, systemic immunotherapies with the potential to be broadly effective in treating solid tumors and...
Other Companies in Phoenix
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 6 | N/A | N/A |
#2 | $0.8M | 6 | -45% | N/A |
#3 | $0.5M | 6 | 0% | N/A |
#4 | $0.7M | 6 | -67% | N/A |
#5 | $0.6M | 6 | N/A | N/A |